➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Harvard Business School
McKesson
Dow
Medtronic

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SOLRIAMFETOL HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for solriamfetol hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03868943 Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma Not yet recruiting National Cancer Institute (NCI) Phase 2 2019-05-01 This phase II trial studies the side effects of solriamfetol in improving sleep in patients with grade II-IV glioma. Solriamfetol is a wakefulness-promoting drug. Giving solriamfetol may improve sleep, memory, fatigue, mood, or quality of life in patients with brain tumors (gliomas).
NCT03868943 Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma Not yet recruiting Wake Forest University Health Sciences Phase 2 2019-05-01 This phase II trial studies the side effects of solriamfetol in improving sleep in patients with grade II-IV glioma. Solriamfetol is a wakefulness-promoting drug. Giving solriamfetol may improve sleep, memory, fatigue, mood, or quality of life in patients with brain tumors (gliomas).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for solriamfetol hydrochloride

Condition Name

Condition Name for solriamfetol hydrochloride
Intervention Trials
Glioblastoma 1
Glioma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for solriamfetol hydrochloride
Intervention Trials
Glioma 1
Glioblastoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for solriamfetol hydrochloride

Clinical Trial Phase

Clinical Trial Phase for solriamfetol hydrochloride
Clinical Trial Phase Trials
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for solriamfetol hydrochloride
Clinical Trial Phase Trials
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for solriamfetol hydrochloride

Sponsor Name

Sponsor Name for solriamfetol hydrochloride
Sponsor Trials
Wake Forest University Health Sciences 1
National Cancer Institute (NCI) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for solriamfetol hydrochloride
Sponsor Trials
Other 1
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.